Purpose: To describe the technique of deep sclerectomy with the new Esnoper-Clip ® implant, the clinical outcome and the anatomic characteristics of filtering blebs, using anterior segment optical coherence tomography (AS-OCT).
INTRODuCTION
In the last years, deep sclerectomy (DS) has gained impor tance in glaucoma surgical treatment. In contrast to trabeculectomy, it enhances aqueous humor outflow acting on the major resistance site without entering the anterior chamber, thus reducing the incidence of intra and postoperative overfiltration, hypotony and its potential sequelae. [1] [2] [3] [4] [5] [6] [7] [8] Moreover, the incidence of cataract, [8] [9] [10] hyphema, 5 endothelial damage 11 and macular edema is lower 5 with DS. Although it is widely accepted that the DS is safer, remains some controversy about the intraocular pressure (IOP)-lowering effects. Chiselita et al 12 and Cheng et al 1 described lower efficacy than trabeculectomy, in contrast to El Sayyad et al 13 complications with one year follow-up) and the anatomic characteristics of filtering blebs, using AS-OCT. To our knowledge, this is the first clinical study to evaluate this new implant.
METhODS

Participant Selection
A prospective case-series study was conducted in five eyes of five patients (4♂: 1♀), with a mean age of 61 ± 15.6 years, followed in Glaucoma Section of Ophthalmology Department of Central Lisbon Hospital Center (Table 1) . Three patients had primary open-angle glaucoma (POAG) and two pseudoexfoliative glaucoma (PEXG), with characteristic structural and functional findings. Two of them had previous cataract surgery for more than 6 months. All patients had uncontrolled glaucoma despite being on maximal medical therapy.
PROCEDuRES
Esnoper-Clip ® is a nonabsorbable foldable implant with two plates (scleral and supraciliary), composed by 2-hydroxyethyl methacrylate, a nonionic polymer with low tendency for protein deposits. Its length, unfolded, is 5.5 mm (3 mm scleral plate and 2.5 mm supraciliary plate), the base width is 2.2 mm and the thickness is 0.2 mm ( flap was sutured with monofilament 10-0 as long as the conjunctiva. In one case, mitomycin C was used during surgery (ethnic and inflammatory factors). All participants underwent a full ophthalmologic examination (including measurement of IOP with Goldmann tonometer) and AS-OCT (Visante ® ) preoperatively, then at 1 day, 1 week, 1 month, 6 months and 1 year postoperatively. Scans were done through sagittal and transversal plans to the implant (Fig. 2) .
The number of glaucoma medications needed to lower IOP, after the surgical procedure, was documented.
STATISTICAL ANALySIS
Statistical analysis was conducted using SPSS Statistics version 20.0. The average and standard deviation (SD) of IOP and number of glaucoma medications were calculated. These values were compared between the different follow-up times using Mann-Whitney test. p-values less than 0.05 were considered statistically significant.
Ethics Statement
The study was approved by the Human Research Ethics Committee of the Central Lisbon Hospital Center and followed the tenets of the Declaration of Helsinki. Written informed consent was obtained from all participants.
RESuLTS
Intraocular pressure and number of glaucoma medications were significantly reduced (p < 0.05) from a preoperative value of 23.4 ± 8.6 mm Hg (n = 3.8 glaucoma medications) to a postoperative value of 6.0 ± 2.5 (n = 0), 10.6 ± 5.4 (n = 0), 13 ± 1.6 (n = 0.4), 12.4 ± 2.1 (n = 0.2) and 14.4 ± 1.5 (n = 0.2) at 1 day, 1 week, 1 month, 6 months and 1 year respectively ( Table 2) . Anterior segment optical coherence tomography allowed the visualization of the two plates of the implant (scleral and supraciliary), the trabeculo descemetic mem brane and the hyporeflective spaces in the bleb wall thickness and in suprascleral and supra-choroidal locali za tions (Figs 3A to C).
JOCGP
As complications we have registered one eye with imme diate postoperative hypotony, which was solved in 9 days, without sequelae. In other patient, we verified the anterio rization of the Esnoper-Clip ® implant associated to trabeculo descemetic membrane rupture at 6-month follow-up ( Figs 4A and B) .
DISCuSSION
Previous studies suggested that DS with the use of implants have good efficacy and low rate of perioperative complications. [1] [2] [3] [4] [5] [6] [7] [8] 14 During the first year of follow-up, we found a maintained postoperative IOP decrease after DS with Esnoper-Clip ® implant, similar to the values published with other implants, 20, 22 with almost no need of glaucoma medications. The hypotony reported happened in the only patient in which mitomycin C was used, and so it may be correlated with its use. The anteriorization of the implant with trabeculodescemetic membrane rupture, registered at 6-month follow-up, did not show significant clinical repercussions or at the aqueous humor drainage, as noticed by the low IOP values measured. In contrast to other implants, such as Esnoper ® , EsnoperClip ® is not sutured to sclera so it may predispose to implant dislocation, a complication that was never been documented in 5 years of experience of the authors with the first implant.
In the last few years, with new technological advances, filtering bleb structure has been studied [by confocal microscopy, 24, 25 ultrasound biomicroscopy (UBM) 20 and AS-OCT [16] [17] [18] [19] [20] [21] [22] [23] [24] ] in order to better understand the drainage pathways and its role on glaucoma surgery success. In this study, AS-OCT allowed to analyze the localization of the implant, the trabeculodescemetic membrane and hyporeflective spaces suggesting liquid content and so its drainage pathways, as already described in the literature. 16, 17, 19, 20 Esnoper-Clip ® implant acts as a space maintainer and leads to the aqueous humor drainage to suprachoroidal, supraescleral and intraconjunctival spaces, as suggested by the images captured by AS-OCT. Therefore, this high-resolution imaging method may complement the clinical evaluation during the followup time.
In order to understand the relevance of this new implant in the clinical practice, further prospective, controlled, randomized and multicenter studies, with larger samples and longer follow-up, would be important. Moreover, studies should be done to compare DS with Esnoper-Clip ® with the use of other implants and with trabeculectomy with or without antimetabolites. Also, structure-function correlation studies, using AS-OCT, would be of value, as is already described for other implants.
17,19-21,23,24
CONCLuSION
Our first five DS with Esnoper-Clip ® implant analysis suggest an effective and well-tolerated method to reduce IOP. AS-OCT is a noninvasive imaging technique that allows morphological analysis of the drainage mechanisms after glaucoma surgery.
